June 17, 2020
1 min read
Save
ODYSSEY HoFH
Issue: June 2020

LDL reduction with alirocumab (Praluent, Sanofi/Regeneron) every 2 weeks vs. placebo in patients with homozygous familial hypercholesterolemia.